A detailed history of Gulf International Bank (Uk) LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 26,814 shares of MRNA stock, worth $1.76 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
26,814
Previous 26,814 -0.0%
Holding current value
$1.76 Million
Previous $2.86 Million 11.45%
% of portfolio
0.08%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$85.37 - $115.44 $19,464 - $26,320
228 Added 0.86%
26,814 $2.86 Million
Q4 2023

Jan 11, 2024

SELL
$69.51 - $104.43 $231,885 - $348,378
-3,336 Reduced 11.15%
26,586 $2.64 Million
Q3 2023

Oct 10, 2023

SELL
$96.41 - $126.61 $304,462 - $399,834
-3,158 Reduced 9.55%
29,922 $3.09 Million
Q2 2023

Aug 02, 2023

SELL
$118.5 - $160.53 $1.17 Million - $1.59 Million
-9,898 Reduced 23.03%
33,080 $4.02 Million
Q1 2023

Apr 12, 2023

SELL
$135.66 - $197.02 $1.88 Million - $2.74 Million
-13,886 Reduced 24.42%
42,978 $6.6 Million
Q4 2021

Jan 24, 2022

SELL
$225.82 - $368.51 $2.55 Million - $4.16 Million
-11,300 Reduced 16.58%
56,864 $14.4 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $861,193 - $1.88 Million
3,881 Added 6.04%
68,164 $26.2 Million
Q2 2021

Aug 10, 2021

BUY
$129.91 - $234.98 $1.01 Million - $1.82 Million
7,753 Added 13.71%
64,283 $15.1 Million
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $655,080 - $1.12 Million
-6,000 Reduced 9.6%
56,530 $7.4 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $302,404 - $781,356
-4,600 Reduced 6.85%
62,530 $6.53 Million
Q3 2020

Oct 21, 2020

SELL
$54.34 - $94.85 $29,887 - $52,167
-550 Reduced 0.81%
67,130 $4.75 Million
Q2 2020

Jul 24, 2020

BUY
$29.67 - $80.0 $2.01 Million - $5.41 Million
67,680 New
67,680 $4.35 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gulf International Bank (Uk) LTD Portfolio

Follow Gulf International Bank (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.